doi: 10.1038/CDDIS.2014.580 185 AnvariSMillerJYehCYDavisCM
Head to head comparison of GLP-1 analogs The clinical results achieved by short-, long, and prolonged-acting GLP-1 analogs have now been tested across different studies and in direct head to head comparison studies
Not only did I achieve my weight goals, but my A1c improved, and Ive experienced fewer migraines
As a result of being peptides, GLP-1 RAs typically have to be given by subcutaneous (s.c.) administration as twice daily (BID) (exenatide) [15, 16], once daily (OD) (lixisenatide [17, 18] and liraglutide [19, 20]) or once weekly (OW) (dulaglutide [21, 22], prolonged-release exenatide [23, 24] and semaglutide [25, 26]) dosing regimens, based on their in vivo half-lives [6]
In addition, the patient was instructed to perform regular self-monitoring of the oral lesions and to promptly contact the treating clinician in the event of any negative or concerning changes
Metabolic health vs obesity